This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
BioMerieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (about 38% of sales), microbiology (about 32%), immunoassays (about 15%), and industrial applications (about 15%). Europe, the Middle East, and Africa accounts for the largest portion of the firm's revenue (38%), followed by North America (38%), Asia-Pacific (17%), and Latin America (7%). BioMerieux is headquartered in Marcy-l'Etoile, France.
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.
What was bioMerieux’s price range in the past 12 months?
bioMerieux lowest stock price was €74.97 and its highest was €144.85 in the past 12 months.
What is bioMerieux’s market cap?
bioMerieux’s market cap is €11.19B.
What is bioMerieux’s price target?
The average price target for bioMerieux is €112.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is €129.00 ,the lowest forecast is €95.00. The average price target represents 17.94% Increase from the current price of €94.96.
What do analysts say about bioMerieux?
bioMerieux’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
When is bioMerieux’s upcoming earnings report date?
bioMerieux’s upcoming earnings report date is Sep 01, 2021 which is next month.
How were bioMerieux’s earnings last quarter?
bioMerieux released its earnings results on Feb 24, 2021. The company reported €1.959 earnings per share for the quarter, beating the consensus estimate of N/A by €1.959.
Is bioMerieux overvalued?
According to Wall Street analysts bioMerieux’s price is currently Undervalued.
Does bioMerieux pay dividends?
bioMerieux pays a Annually dividend of €0.62 which represents an annual dividend yield of 0.85%. bioMerieux’s last Annually dividend payment was on Jun 08, 2021. bioMerieux’s upcoming ex-dividend date is Jun 04, 2021
What is bioMerieux’s EPS estimate?
bioMerieux’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does bioMerieux have?
bioMerieux has 117,870,000 shares outstanding.
What happened to bioMerieux’s price movement after its last earnings report?
bioMerieux reported an EPS of €1.959 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.544%.
Which hedge fund is a major shareholder of bioMerieux?
Currently, no hedge funds are holding shares in GB:0RUG